VEGFR3 Inhibition Chemosensitizes Ovarian Cancer Stemlike Cells through Down-Regulation of BRCA1 and BRCA2

by Jaeyoung Lim, Kun Yang, Barbie Taylor-Harding, W. Ruprecht Wiedemeyer, Ronald J. Buckanovich
Published 2014-04-01

Are Epithelial Ovarian Cancers of the Mesenchymal Subtype Actually Intraperitoneal Metastases to the Ovary?

by Ye Hu, Ye Hu, Barbie Taylor-Harding, Barbie Taylor-Harding, Yael Raz, Yael Raz, Marcela Haro, Marcela Haro, Maria Sol Recouvreux, Maria Sol Recouvreux, Enes Taylan, Enes Taylan, Jenny Lester, Joshua Millstein, Ann E. Walts, Beth Y. Karlan, Beth Y. Karlan, Sandra Orsulic, Sandra Orsulic, Sandra Orsulic
Published 2020-07-01

Tumors defective in homologous recombination rely on oxidative metabolism: relevance to treatments with PARP inhibitors

by Álvaro Lahiguera, Petra Hyroššová, Agnès Figueras, Diana Garzón, Roger Moreno, Vanessa Soto‐Cerrato, Iain McNeish, Violeta Serra, Conxi Lazaro, Pilar Barretina, Joan Brunet, Javier Menéndez, Xavier Matias‐Guiu, August Vidal, Alberto Villanueva, Barbie Taylor‐Harding, Hisashi Tanaka, Sandra Orsulic, Alexandra Junza, Oscar Yanes, Cristina Muñoz‐Pinedo, Luís Palomero, Miquel Àngel Pujana, José Carlos Perales, Francesc Viñals
Published 2020-06-01